J&J Balks At Ark.'s $181M Risperdal Legal Fee Request

Law360, New York (December 13, 2012, 2:57 PM EST) -- Johnson & Johnson challenged Arkansas' request for $181 million in legal fees for attorneys who secured a $1.2 billion judgment in a Medicaid fraud case over marketing of the antipsychotic drug Risperdal, telling a state judge Wednesday that lawyers representing the state should receive no more than $4 million.

During a hearing in Pulaski County court, J&J claimed that the state has failed to justify the 15 percent award with any detailed time and labor estimates. The state agreed to the rate in a fee contract...
To view the full article, register now.